Image

CMV-MVA Triplex Vaccination in HLA-Matched Related Stem Cell Donors for the Prevention of CMV Infection in Patients Undergoing Hematopoietic Stem Cell Transplant

Study on CMV vaccine to help transplant patients avoid infection.

Recruiting
18-75 years
All
Phase 2

This study is about a vaccine called CMV-MVA Triplex. It aims to help people who are getting a stem cell transplant avoid a virus called cytomegalovirus (CMV). The vaccine is given to donors, who are people giving stem cells. The vaccine helps the donor's body fight CMV, and this protection is passed to the recipient, or patient, during the transplant.

In this study, donors are divided into two groups. One group gets the vaccine, and the other gets a placebo, which is a shot that doesn't have the vaccine. After receiving the vaccine or placebo, donors go through a process to collect their stem cells. Meanwhile, patients are prepared for the transplant and receive the stem cells within nine weeks.

  • Time Commitment: Donors follow up for a year; recipients have several follow-ups within a year post-transplant.
  • Eligibility: Requires informed consent and specific health criteria for both donors and recipients.
  • Risks: Participants should discuss potential risks with their healthcare providers.
Study details
    Acute Lymphoblastic Leukemia
    Acute Myeloid Leukemia
    Chronic Lymphocytic Leukemia
    Chronic Myeloid Leukemia
    BCR-ABL1 Positive
    Hematopoietic and Lymphoid System Neoplasm
    Hodgkin Lymphoma
    Myelodysplastic Syndrome
    Myelofibrosis
    Myeloproliferative Neoplasm
    Non-Hodgkin Lymphoma

NCT06059391

City of Hope Medical Center

15 March 2025

Step 1 Get in touch with the nearest study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

  Other languages supported:

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.